Ibio Inc Stock Shares Owned By Institutions
IBIO Stock | USD 1.81 0.07 3.72% |
Ibio Inc fundamentals help investors to digest information that contributes to Ibio's financial success or failures. It also enables traders to predict the movement of Ibio Stock. The fundamental analysis module provides a way to measure Ibio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ibio stock.
Ibio | Shares Owned By Institutions |
Ibio Inc Company Shares Owned By Institutions Analysis
Ibio's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Ibio Shares Owned By Institutions | 26.48 % |
Most of Ibio's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Ibio Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Ibio Shares Owned By Institutions Driver Correlations
Understanding the fundamental principles of building solid financial models for Ibio is extremely important. It helps to project a fair market value of Ibio Stock properly, considering its historical fundamentals such as Shares Owned By Institutions. Since Ibio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Ibio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Ibio's interrelated accounts and indicators.
Click cells to compare fundamentals
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 26.479% of Ibio Inc are shares owned by institutions. This is 40.68% lower than that of the Biotechnology sector and 44.25% lower than that of the Health Care industry. The shares owned by institutions for all United States stocks is 32.47% higher than that of the company.
Ibio Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ibio's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Ibio could also be used in its relative valuation, which is a method of valuing Ibio by comparing valuation metrics of similar companies.Ibio is currently under evaluation in shares owned by institutions category among related companies.
Ibio Fundamentals
Return On Equity | -1.48 | ||||
Return On Asset | -0.3 | ||||
Operating Margin | (414.66) % | ||||
Current Valuation | 21.04 M | ||||
Shares Outstanding | 8.61 M | ||||
Shares Owned By Insiders | 0.18 % | ||||
Shares Owned By Institutions | 26.48 % | ||||
Number Of Shares Shorted | 135.22 K | ||||
Price To Earning | (2.18) X | ||||
Price To Book | 1.87 X | ||||
Price To Sales | 344.02 X | ||||
Revenue | 50 K | ||||
Gross Profit | 2.17 M | ||||
EBITDA | (28.11 M) | ||||
Net Income | (65.01 M) | ||||
Cash And Equivalents | 33.52 M | ||||
Cash Per Share | 3.72 X | ||||
Total Debt | 17.07 M | ||||
Debt To Equity | 0.44 % | ||||
Current Ratio | 1.48 X | ||||
Book Value Per Share | 2.83 X | ||||
Cash Flow From Operations | (30.44 M) | ||||
Short Ratio | 0.18 X | ||||
Earnings Per Share | (15.25) X | ||||
Target Price | 1.0 | ||||
Number Of Employees | 26 | ||||
Beta | -3.25 | ||||
Market Capitalization | 16.19 M | ||||
Total Asset | 41.21 M | ||||
Retained Earnings | (288.94 M) | ||||
Working Capital | 4.68 M | ||||
Current Asset | 23.91 M | ||||
Current Liabilities | 2.29 M | ||||
Net Asset | 41.21 M |
About Ibio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ibio Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ibio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ibio Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Ibio Piotroski F Score and Ibio Altman Z Score analysis. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Complementary Tools for Ibio Stock analysis
When running Ibio's price analysis, check to measure Ibio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ibio is operating at the current time. Most of Ibio's value examination focuses on studying past and present price action to predict the probability of Ibio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ibio's price. Additionally, you may evaluate how the addition of Ibio to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is Ibio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (15.25) | Revenue Per Share 0.044 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (1.48) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ibio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.